Corton Capital’s Nuvation Bio NUVB Stock Holding History

Corton Capital’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,760	Closed	-$67K	–	461
2022 Q1	$67K	Buy	+12,760	New	+$71.7K	0.03%	404

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Corton Capital's NUVB Position: Q2 2022 in Review

Corton Capital sold out of Nuvation Bio (NUVB) in Q2 2022, closing a stake of 12,760 shares — an estimated $67K sold.

Corton Capital first reported a position in NUVB in Q1 2022 and held it in 1 quarter. The position peaked at $67K in Q1 2022. 119 funds tracked by Wall St. Rank hold NUVB as of Q2 2022.

Corton Capital reported no remaining Nuvation Bio position as of Q2 2022 after selling out during the quarter.
Corton Capital sold 12,760 Nuvation Bio shares in Q2 2022, an estimated $67K.
Corton Capital first reported a position in Nuvation Bio in Q1 2022 and held it in 1 quarter.
Corton Capital's Nuvation Bio position peaked at $67K in Q1 2022.
119 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2022.

Based on Corton Capital's 13F filing for Q2 2022, filed 15 Aug 2022.